Meeting
2013 ASCO Annual Meeting
Comprehensive profiling of cardiac dysfunction in asymptomatic childhood cancer survivors (CCS) treated with anthracyclines.
Authors
Saro Armenian
City of Hope, Duarte, CA
Saro Armenian , Sarah Gelehrter , Tabitha Vase , Rajkumar Venkatramani , Wendy Landier , Karla Wilson , Claudia Herrera , Leah Reichman , John David Menteer , Leo Mascarenhas , David Robert Freyer , Kalyanasundaram Venkataraman , Smita Bhatia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Survivorship
Citation
J Clin Oncol 31, 2013 (suppl; abstr 10020)
DOI
10.1200/jco.2013.31.15_suppl.10020
Abstract #
10020
Poster Bd #
35C
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from Children’s Oncology Group and Childhood Cancer Survivor Study.
First Author: Noha Sharafeldin
Poster
2019 ASCO Annual Meeting
A novel association between GSTM1 null variant and anthracycline-induced cardiac dysfunction (ACD) in childhood cancer survivors (CCS): A COG ALTE03N1 report.
First Author: Purnima Singh
Poster
2017 ASCO Annual Meeting
Endothelial dysfunction in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort study.
First Author: Daniel A. Mulrooney
Poster
2023 ASCO Annual Meeting
A genome-wide association study for doxorubicin-induced cardiomyopathy in childhood cancer survivors from the St. Jude Lifetime Cohort (SJLIFE) and the Childhood Cancer Survivor (CCSS) Studies.
First Author: Kateryna Petrykey